Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 84,833	$ 114,195
Prepaid expenses and other current assets	3,513	1,435
Total current assets	88,346	115,630
Operating lease asset, net	768	138
Goodwill	48,648	48,648
In-process research and development	32,386	32,386
Other assets	400	383
Total assets	170,548	197,185
Current liabilities:
Accounts payable	1,813	1,366
Current operating lease liability	369	144
Accrued expenses and other liabilities	2,219	973
Total current liabilities	4,401	2,483
Deferred tax liability	1,752	4,106
Non-current operating lease liability	400
Total liabilities	6,553	6,589
Commitments and contingencies (Note 5)
Stockholders’ equity:
Common stock, $0.001 par value, 200,000,000 shares authorized at December 31, 2021 and 2020; 14,306,788 and 15,160,397 shares issued and outstanding at December 31, 2021 and 2020, respectively	14	15
Additional paid-in capital	278,880	270,974
Accumulated deficit	(114,899)	(80,393)
Total stockholders’ equity	163,995	190,596
Total liabilities and stockholders’ equity	170,548	197,185
Series X1 Non-voting Convertible Preferred Stock [Member]
Stockholders’ equity:
Preferred stock, value
Series X Non-voting Convertible Preferred Stock [Member]
Stockholders’ equity:
Preferred stock, value

In-process research and development.

No definition available.

Name:	eldn_InProcessResearchAndDevelopment
Namespace Prefix:	eldn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).